Seres Therapeutics(MCRB) - 2022 Q3 - Quarterly Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Delaware 27-4326290 (State or other jurisdiction of incorporation or organization) 200 Sidney Street - 4 Floor Cambridge, MA 02139 (Address of principal executive offices) (Zip Code) th (I.R.S. Employer Identification No.) (617) 945-9626 For the quarterly period ended September 30, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTIO ...